235 related articles for article (PubMed ID: 21858080)
1. Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing.
Pastor T; Pagani F
PLoS One; 2011; 6(8):e23349. PubMed ID: 21858080
[TBL] [Abstract][Full Text] [Related]
2. An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM.
Pastor T; Talotti G; Lewandowska MA; Pagani F
Nucleic Acids Res; 2009 Nov; 37(21):7258-67. PubMed ID: 19773425
[TBL] [Abstract][Full Text] [Related]
3. The intronic splicing code: multiple factors involved in ATM pseudoexon definition.
Dhir A; Buratti E; van Santen MA; Lührmann R; Baralle FE
EMBO J; 2010 Feb; 29(4):749-60. PubMed ID: 20094034
[TBL] [Abstract][Full Text] [Related]
4. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.
Goina E; Skoko N; Pagani F
Mol Cell Biol; 2008 Jun; 28(11):3850-60. PubMed ID: 18391021
[TBL] [Abstract][Full Text] [Related]
5. Functional studies on the ATM intronic splicing processing element.
Lewandowska MA; Stuani C; Parvizpur A; Baralle FE; Pagani F
Nucleic Acids Res; 2005; 33(13):4007-15. PubMed ID: 16030351
[TBL] [Abstract][Full Text] [Related]
6. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.
Guil S; Gattoni R; Carrascal M; Abián J; Stévenin J; Bach-Elias M
Mol Cell Biol; 2003 Apr; 23(8):2927-41. PubMed ID: 12665590
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
8. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
9. Changes in splicing factor expression are associated with advancing age in man.
Holly AC; Melzer D; Pilling LC; Fellows AC; Tanaka T; Ferrucci L; Harries LW
Mech Ageing Dev; 2013 Sep; 134(9):356-66. PubMed ID: 23747814
[TBL] [Abstract][Full Text] [Related]
10. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.
Buratti E; Dhir A; Lewandowska MA; Baralle FE
Nucleic Acids Res; 2007; 35(13):4369-83. PubMed ID: 17580311
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a.
Coutinho G; Xie J; Du L; Brusco A; Krainer AR; Gatti RA
Hum Mutat; 2005 Feb; 25(2):118-24. PubMed ID: 15643608
[TBL] [Abstract][Full Text] [Related]
12. FUBP1: a new protagonist in splicing regulation of the DMD gene.
Miro J; Laaref AM; Rofidal V; Lagrafeuille R; Hem S; Thorel D; Méchin D; Mamchaoui K; Mouly V; Claustres M; Tuffery-Giraud S
Nucleic Acids Res; 2015 Feb; 43(4):2378-89. PubMed ID: 25662218
[TBL] [Abstract][Full Text] [Related]
13. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
[TBL] [Abstract][Full Text] [Related]
14. Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing.
Rappe U; Schlechter T; Aschoff M; Hotz-Wagenblatt A; Hofmann I
J Biol Chem; 2014 May; 289(18):12421-34. PubMed ID: 24644279
[TBL] [Abstract][Full Text] [Related]
15. HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo.
Howard JM; Lin H; Wallace AJ; Kim G; Draper JM; Haeussler M; Katzman S; Toloue M; Liu Y; Sanford JR
Genome Res; 2018 May; 28(5):689-698. PubMed ID: 29650551
[TBL] [Abstract][Full Text] [Related]
16. An intron enhancer recognized by splicing factors activates polyadenylation.
Lou H; Gagel RF; Berget SM
Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
[TBL] [Abstract][Full Text] [Related]
17. An ataxia-telangiectasia-mutated (ATM) kinase mediated response to DNA damage down-regulates the mRNA-binding potential of THOC5.
Ramachandran S; Tran DD; Klebba-Faerber S; Kardinal C; Whetton AD; Tamura T
RNA; 2011 Nov; 17(11):1957-66. PubMed ID: 21937706
[TBL] [Abstract][Full Text] [Related]
18. RBM5 promotes exon 4 skipping of AID pre-mRNA by competing with the binding of U2AF65 to the polypyrimidine tract.
Jin W; Niu Z; Xu D; Li X
FEBS Lett; 2012 Nov; 586(21):3852-7. PubMed ID: 23017209
[TBL] [Abstract][Full Text] [Related]
19. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.
Sen S; Talukdar I; Liu Y; Tam J; Reddy S; Webster NJ
J Biol Chem; 2010 Aug; 285(33):25426-37. PubMed ID: 20519504
[TBL] [Abstract][Full Text] [Related]
20. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
Kashima T; Rao N; David CJ; Manley JL
Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
